GlassScriptPhysician profile
Nikita Mishra
NPI 1639490477
$2,889.42
in general payments reported to CMS, 2019-2025
28 companies · $77.78 in 2025
The $77.78 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $48.82 · 2021: $1,332 · 2022: $457 · 2023: $411 · 2024: $112 · 2025: $77.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $601.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,367.82 | 2021-2022 | |
| Coloplast Corp | $218.08 | 2023 | Altis |
| Bayer Healthcare Pharmaceuticals INC. | $138.67 | 2020-2024 | |
| Abbvie INC. | $117.10 | 2019-2023 | |
| Organon LLC | $107.89 | 2021-2024 | Nexplanon |
| Coopersurgical, INC. | $95.00 | 2019 | |
| Pfizer INC. | $77.39 | 2019-2024 | |
| Abbott Laboratories | $74.01 | 2024-2025 | Amplatzer |
| Ethicon US, LLC | $71.25 | 2022 | |
| Astellas Pharma US INC | $70.99 | 2019 | |
| Sumitomo Pharma America, INC. | $68.14 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $52.88 | 2019-2025 | Aptima |
| Merck Sharp & Dohme LLC | $47.92 | 2019-2021 | |
| Aspira Women'S Health INC | $45.81 | 2022-2023 | Ova1 |
| Exeltis, USA INC. | $45.06 | 2022-2023 | Slynd |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $44.53 | 2019 | |
| Duchesnay USA Incorporated | $43.84 | 2019 | |
| Amgen INC. | $27.84 | 2019 | |
| Boston Scientific Corporation | $26.46 | 2025 | Wavewriter Alpha Prime 16 |
| Agile Therapeutics, INC. | $22.13 | 2022 | |
| Myovant Sciences INC. | $19.43 | 2022 | |
| Avion Pharmaceuticals | $18.68 | 2022 | |
| Allergan, INC. | $18.22 | 2019 | |
| Amag Pharmaceuticals, INC. | $17.26 | 2020 | |
| Mylan Pharmaceuticals INC. | $16.72 | 2022 | |
| Smith+Nephew, INC. | $14.04 | 2019 | |
| Lupin INC. | $11.43 | 2019 | |
| Vertical Pharmaceuticals, LLC | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikita Mishra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.